Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
International issues on the agenda as Frances's Macron visits China - 2Interpreter Starts Sobbing as 11-Year-Old Testifies About Last Time He Saw His Mom Before She Was Killed in Missile Strike
- 3Lower-cost space missions like NASA's ESCAPADE are starting to deliver exciting science – but at a price in risk and trade‑offs
- 4Picking Childcare Administrations for Your Loved ones
- 5Early diagnosis leads King Charles to scale back cancer treatment in the new year
- Health insurance premiums rose nearly 3x the rate of worker earnings over the past 25 years
- EU agrees on agriculture safeguards as fronts harden in Mercosur deal
- Hezbollah claims right to respond to killing of top commander
- Savvy Tips for Seniors Hyundai IONIQ EV
- He made a name for himself posting thirst traps on TikTok. Now he's the star of a wildly popular rom-com.
- Bad flu season getting worse; skyrocketing cases set state record
- Thousands of New York City nurses set to strike Monday if deal isn't reached with hospitals
- Step by step instructions to Protect Your Retirement with Senior Protection.
- Former United Launch Alliance CEO Tory Bruno joins competitor Blue Origin for national security projects
